EUVIMEDObjevte EUVIMED
Crossref

Immunogenic and immunotolerogenic effects of extracorporeal photopheresis in high immunological risk kidney recipients. A single center case series

Marc Xipell iD, Alícia Molina-Andújar, Joan Cid iD, Gastón J Piñeiro, Enrique Montagud-Marrahi iD, Frederic Cofan, Frederic Oppenheimer, Jordi Rovira, Fritz Diekmann, Miquel Lozano iD

Journal of Clinical Apheresis · 2022-06 · 37 (3) · 197-205

DOI: 10.1002/jca.21958 ↗

At a glance

Journal article in Journal of Clinical Apheresis, published online on 2021-12-22. Written by Marc Xipell and 9 co-authors. Institution: Nephrology and Renal Transplantation Department, Hospital Clínic de Barcelona, Barcelona, Spain. Major MEDLINE topics: Kidney Transplantation, Photopheresis. Cited 12 times so far (Crossref); 44 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The immunomodulatory effects of extracorporeal photopheresis (ECP) have been used for the treatment of T‐cell mediated disorders, such as rejection in organ transplantation. Currently, it is an established therapy for heart and lung rejection, but not for kidney transplantation (KT), where experience is limited. In addition, some data suggest that ECP could generate an immune response against infections, thus being an alternative for the treatment of rejection in case of active or high‐risk of infection. In the present study, we analyze four cases of use of ECP as concomitant therapy in patients with KT and high risk of opportunistic infections due to the high burden of immunosuppression throughout their renal diseases. Two patients had concomitant viral infection (cytomegalovirus and BK virus, respectively) and three patients were on treatment for graft rejection. In the two patients with active viral infection, the infection was successfully controlled during ECP treatment. In all cases, ECP has been shown to be a safe procedure, without complications.

Subjects

MeSH terms (MEDLINE)

Kidney TransplantationPhotopheresisGraft RejectionHumansImmunosuppression TherapyKidney

Author keywords

extracorporeal photopheresisinfectionkidney transplantrejection

Authors and institutions

  • Nephrology and Renal Transplantation Department, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Laboratori Experimental de Nefrologia I Trasplantament, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain.
  • Apheresis Unit, Department of Hemotherapy and Hemostasis, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Red de Investigación Renal (REDINREN), Instituto de Salud Carlos III, Madrid, Spain.

ORCID profiles: Marc Xipell, Joan Cid, Enrique Montagud-Marrahi, Miquel Lozano

Cite

APA

Xipell, M., Molina-Andújar, A., Cid, J., Piñeiro, G. J., Montagud-Marrahi, E., Cofan, F., Oppenheimer, F., Rovira, J., Diekmann, F., & Lozano, M. (2022). Immunogenic and immunotolerogenic effects of extracorporeal photopheresis in high immunological risk kidney recipients. A single center case series. Journal of Clinical Apheresis, 37(3), 197-205. https://doi.org/10.1002/jca.21958

Vancouver

Xipell M, Molina-Andújar A, Cid J, Piñeiro GJ, Montagud-Marrahi E, Cofan F, et al. Immunogenic and immunotolerogenic effects of extracorporeal photopheresis in high immunological risk kidney recipients. A single center case series. Journal of Clinical Apheresis. 2022;37(3):197-205. doi:10.1002/jca.21958

BibTeX
@article{Xipell2022,
  author = {Xipell, Marc and Molina-Andújar, Alícia and Cid, Joan and Piñeiro, Gastón J and Montagud-Marrahi, Enrique and Cofan, Frederic and Oppenheimer, Frederic and Rovira, Jordi and Diekmann, Fritz and Lozano, Miquel},
  title = {Immunogenic and immunotolerogenic effects of extracorporeal photopheresis in high immunological risk kidney recipients. A single center case series},
  journal = {Journal of Clinical Apheresis},
  year = {2022},
  volume = {37},
  number = {3},
  pages = {197--205},
  doi = {10.1002/jca.21958}
}
Start for free →